Fund II will invest in disruptive consumer brands at seed stage up to Series A, cutting checks of around a million dollars with 25-30% of the fund reserved for follow on investments
The ever-popular gut microbiome sector must create a run-to-poop future that moves beyond just science and into storytelling.
The Rarebird version of coffee could increase alertness in individuals without the anxiety often associated with caffeine.
The San Francisco-based startup will use the funds to bring its first ingredient, which is aimed at improving gut health, to market.
The future of food is exciting and unknown; but one way or another, it’s going to require more consumer education, writes Soylent’s Demir Vangelov.
His startup aims to combine the nutrients of traditional whey powder with a taste that’s superior to existing plant-based offerings.
Users can order health-conscious meals, groceries, and supplements through the Indian startup’s wellness marketplace.
Sponsored
Sponsored post: The innovator’s dilemma: why agbioscience innovation must focus on the farmer first